会員登録
ログイン
【4936】アクシージア
化粧品及びサプリメント製造・販売事業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025.07 | 2024/09/13 | 当初予 | 15,417 | - | - | - | 941 | - | - | - | 906 | - | - | - | 636 | - | - | - |
| 2024.07 | 2024/09/13 | 実 | 12,192 | ↓ | -0.1% | -6.2% | 918 | ↑ | +10.6% | -61.7% | 1,122 | ↑ | +7.9% | -51.2% | 794 | ↑ | +13.4% | -51.4% |
| 2024.07 | 2024/06/14 | Q3予 | 12,200 | ↑ | +7.0% | -6.2% | 830 | ↑ | +12.2% | -65.4% | 1,040 | ↑ | +30.0% | -54.8% | 700 | ↑ | +32.1% | -57.2% |
| 2024.07 | 2024/03/14 | Q2予 | 11,400 | ↓ | -12.3% | -12.3% | 740 | ↓ | -69.2% | -69.2% | 800 | ↓ | -65.2% | -65.2% | 530 | ↓ | -67.6% | -67.6% |
| 2024.07 | 2023/12/15 | Q1予 | 13,000 | → | 0.0% | 0.0% | 2,400 | → | 0.0% | 0.0% | 2,300 | → | 0.0% | 0.0% | 1,635 | → | 0.0% | 0.0% |
| 2024.07 | 2023/09/14 | 当初予 | 13,000 | - | - | - | 2,400 | - | - | - | 2,300 | - | - | - | 1,635 | - | - | - |
| 2023.07 | 2023/09/14 | 実 | 11,341 | ↑ | +9.6% | +9.6% | 1,899 | ↑ | +4.5% | +4.5% | 1,902 | ↑ | +5.8% | +5.8% | 1,330 | ↑ | +13.5% | +13.5% |
| 2023.07 | 2023/06/12 | Q3予 | 10,351 | → | 0.0% | 0.0% | 1,818 | → | 0.0% | 0.0% | 1,797 | → | 0.0% | 0.0% | 1,172 | → | 0.0% | 0.0% |
| 2023.07 | 2023/03/13 | Q2予 | 10,351 | → | 0.0% | 0.0% | 1,818 | → | 0.0% | 0.0% | 1,797 | → | 0.0% | 0.0% | 1,172 | → | 0.0% | 0.0% |
| 2023.07 | 2022/12/12 | Q1予 | 10,351 | → | 0.0% | 0.0% | 1,818 | → | 0.0% | 0.0% | 1,797 | → | 0.0% | 0.0% | 1,172 | → | 0.0% | 0.0% |
| 2023.07 | 2022/09/14 | 当初予 | 10,351 | - | - | - | 1,818 | - | - | - | 1,797 | - | - | - | 1,172 | - | - | - |
| 2022.07 | 2022/09/14 | 実 | 8,215 | ↑ | +2.7% | +15.4% | 1,633 | ↑ | +8.9% | +11.4% | 1,746 | ↑ | +9.1% | +22.6% | 1,116 | ↑ | +6.3% | +20.0% |
| 2022.07 | 2022/07/14 | 修正予 | 8,000 | ↑ | +12.4% | +12.4% | 1,500 | ↑ | +2.3% | +2.3% | 1,600 | ↑ | +12.4% | +12.4% | 1,050 | ↑ | +12.9% | +12.9% |
| 2022.07 | 2022/06/29 | Q3予 | 7,117 | → | 0.0% | 0.0% | 1,466 | → | 0.0% | 0.0% | 1,424 | → | 0.0% | 0.0% | 930 | → | 0.0% | 0.0% |
| 2022.07 | 2022/03/11 | Q2予 | 7,117 | → | 0.0% | 0.0% | 1,466 | → | 0.0% | 0.0% | 1,424 | → | 0.0% | 0.0% | 930 | → | 0.0% | 0.0% |
| 2022.07 | 2021/12/10 | Q1予 | 7,117 | → | 0.0% | 0.0% | 1,466 | → | 0.0% | 0.0% | 1,424 | → | 0.0% | 0.0% | 930 | → | 0.0% | 0.0% |
| 2022.07 | 2021/09/13 | 当初予 | 7,117 | - | - | - | 1,466 | - | - | - | 1,424 | - | - | - | 930 | - | - | - |
| 2021.07 | 2021/09/13 | 実 | 5,787 | ↑ | +3.3% | +11.9% | 1,383 | ↑ | +2.4% | +7.8% | 1,370 | ↑ | +1.5% | +9.4% | 868 | ↑ | +2.1% | -1.7% |
| 2021.07 | 2021/06/10 | Q3予 | 5,600 | ↑ | +8.3% | +8.3% | 1,350 | ↑ | +5.2% | +5.2% | 1,350 | ↑ | +7.8% | +7.8% | 850 | ↓ | -3.7% | -3.7% |
| 2021.07 | 2021/03/10 | 当初予 | 5,172 | - | - | - | 1,283 | - | - | - | 1,252 | - | - | - | 883 | - | - | - |
